TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts

John R Hawse1, Muzaffer Cicek, Sarah B Grygo

  • 1Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America. hawse.john@mayo.edu

Plos One
|May 12, 2011
PubMed

Insights

TIEG1 (Thymus expression 1) is crucial for bone health, particularly in females. Its absence impairs Runx2 expression, leading to osteopenia. Restoring Runx2 corrects bone defects in TIEG1 knockout mice.

Area of Science:

  • Bone Biology
  • Molecular Endocrinology
  • Genetics

Background:

  • TIEG1/KLF10 is implicated in skeletal development.
  • Osteoporosis is a significant health concern, especially in postmenopausal women.
  • Runx2 is a master regulator of osteoblast differentiation and bone formation.

Purpose of the Study:

  • To investigate the role of TIEG1 in regulating Runx2 expression and its contribution to osteopenia.
  • To elucidate the molecular mechanisms by which TIEG1 influences osteoblast function.
  • To determine if TIEG1-mediated regulation of Runx2 is essential for maintaining bone mass.

Main Methods:

  • Generation and analysis of TIEG1 knockout mice.
  • Isolation and culture of calvarial osteoblasts.
  • Gene expression analysis (RT-qPCR).
  • Transient transfection and chromatin immunoprecipitation (ChIP) assays.
  • Co-immunoprecipitation and co-localization studies.
  • Adenoviral rescue experiments.

Main Results:

  • TIEG1 deletion causes gender-specific osteopenia in mice, affecting cortical and trabecular bone.
  • TIEG1 knockout osteoblasts show reduced Runx2 expression and impaired mineralization.
  • TIEG1 directly binds to and activates the Runx2 promoter.
  • TIEG1 interacts with Runx2, co-activating its transcriptional activity.
  • Restoration of Runx2 in TIEG1 knockout osteoblasts rescues differentiation and mineralization defects.

Conclusions:

  • TIEG1 is a critical regulator of Runx2 expression and activity in osteoblasts.
  • Downregulation of Runx2 due to TIEG1 deficiency contributes to osteopenic bone phenotype.
  • TIEG1 represents a potential therapeutic target for osteoporosis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...